Home   Chapter Home   Jobs   Conferences   Fellowships   Books

 

 

 

 

Breast-malignant, males, children

Apocrine carcinoma

 

Author: Nat Pernick, M.D, PathologyOutlines.com, Inc.

Reviewer: Daniel Visscher, M.D., University of Michigan Hospitals, February 2009 (see Reviewers page)

Revised: 8 September 2009

Last major update: September 2009

Copyright: (c) 2002-2009, PathologyOutlines.com, Inc.

 

Definition

=========================================================================

● >90% of tumor cells have cytologic or immunohistochemical features of apocrine cells

● Rare, 1-4% of all breast carcinomas

 

Case reports

=========================================================================

● 46 year old woman (Univ Pittsburgh Case #209)

71 year old woman with nipple (skin) tumor (Cases J 2008 Aug 12;1(1):88)

● 84 year old woman (Case of the Week #68)

 

Treatment and prognosis

=========================================================================

● Similar (Breast J 2008;14:164), or slightly better (Breast 2005;14:3) prognosis as invasive ductal carcinoma

 

Gross description

=========================================================================

● May be mural nodule within cyst

● Often multicentric (Breast Cancer Res Treat 2004;88:49)

 

Microscopic description / grading

=========================================================================

● Tumor cells have distinct cell margins, acidophilic cytoplasm with eosinophilic granules, central to eccentric vesicular nuclei with prominent nucleoli

● May have glandular differentiation with apocrine snouts

● Limit diagnosis to tumors with widespread apocrine change and obvious malignancy

Type A cells: abundant granular and intensely eosinophilic cytoplasm, granules are PAS+ diastase resistant, nuclei vary from globoid with prominent nucleoli to hyperchromatic

Type B cells: abundant cytoplasm with fine empty vacuoles, creating a foamy appearance resembling histiocytes, nuclei are similar to type A cells

 

Micro images

=========================================================================

 

    

Low power                           Cancerization of lobule

 

 

         

Case of the week images

 

 

    

Low power                                High power

 

 

                                           

Cells have abundant cytoplasm                     Cytoplasm is granular, nuclei

with distinct cell margins                                 are round with prominent nucleoli

 

 

                    

GCDFP-15 #1                        #2 (most cells stain)          bcl2 negative

 

 

AFIP Fascicle Third Series

                                                       

Tumor with solid growth pattern                    Histiocytoid variant with isolated cells resembling

                                                                                histiocytes in desmoplastic stroma, may be confused

                                                                                with granular cell tumor

 

Other images: cells have abundant cytoplasm with distinct cell margins #1#2#3cytoplasm is granular, nuclei are round with prominent nucleoli #1#2#3#4#5with apocrine DCIS

 

Positive stains

=========================================================================

● Keratin, GCDFP-15 (76-100%), B72.3 (92%, APMIS 2006;114:712), PAS (granules)

● ER-beta (73%, Histopathology 2007;50:425), particularly ER-beta1 (APMIS 2008;116:923)

● Androgen receptor (54%)

● HER2 (33%), p53 (29-39%), Ki-67

● Note that GCDFP-15 and AR expression decrease in larger or node-positive tumors (Histopathology 2005;47:195)

 

Negative stains

=========================================================================

● ER-alpha (usually), PR (usually), bcl-2

 

Electron microscopy

=========================================================================

● Prominent mitochondria, some with abnormal cristae

● Large membrane bound vesicles with dense homogenous osmophilic cores

 

Electron microscopy images

=========================================================================

 

                         

Cytoplasm is rich in organelles                      Electron dense granules, condensed,

                                                                                at secretory pole of cell

 

 

AFIP Fascicle Third Series

                                                       

Smooth and rough endoplasmic                    Cytokeratin filaments (arrow),

reticulum, dense nucleoli                                 lipid droplets, mitochondria,

                                                                                lysosomes

 

 

Cytoplasm contains numerous lysosomes, lipid droplets,

dilated mitochondria and vesicular endoplasmic reticulum

 

Molecular / cytogenetics

=========================================================================

● Form a distinct, even if heterogeneous, molecular subgroup of breast carcinomas that recapitulate the phenotype of apocrine sweat glands (Mol Oncol 2009 Feb 3 [Epub ahead of print])

● Abnormalities at 7q (codes for GCDFP-15 and prolactin-inducible protein)

● Also loss of heterozygosity for p53 gene, VHL (3p25) gene, NB gene (1p35-36), PKD1/TSC2 gene at 16p13 (Mod Path 1999;12:1083)

 

Differential diagnosis

=========================================================================

● Apocrine metaplasia - not infiltrative, no atypia

● Histiocytic proliferation

● Inflammation

● Granular cell tumors

 

Additional references

=========================================================================

Pathol Res Pract 2008;204:367, Breast Cancer 2002;9:43, Stanford University

 

End of Breast – Malignant, Males, Children > Apocrine carcinoma

 

 

 

This information is intended for physicians and related personnel, who understand that medical information is often imperfect, and must also be interpreted in the context of a patient's clinical data using reasonable medical judgment.  This website should not be used as a substitute for the advice of a licensed physician.

 

All information on this website is protected by Copyright, (c) 2001-2009, PathologyOutlines.com, Inc.  Information from third parties may also be protected by copyright.  Please contact us at copyrightPathOut@gmail.com with any questions.